broker research

The key items brokers are looking out for in upcoming H1 FY24 results for major ASX tech stocks, as well as today’s numbers from REA Group.

With ASX nickel producers hurting, Morgan Stanley considers the demand & supply factors for nickel to determine if it has troughed.

Bell Potter, Citi, and Shaw and Partners have issued updated research on ASX uranium stocks resulting in ratings and price target changes.

Current ASX P/E levels are above average, but they're not yet at levels typically associated with major market corrections.

Data this week showed China’s birth rate continues to slow, triggering Citi to issue an update on infant formula manufacturer a2 Milk.

Goldman Sachs has reviewed Aussie banks, revealing its preferred picks as well as those to avoid.

JP Morgan has released its quarterly outlook for crude oil resulting in changes to the broker’s estimates for is ASX energy coverage.

Macquarie sees potential for further weakness in lithium prices, triggering downgrades and slashed price targets for ASX lithium stocks.

Macquarie has reviewed the Sigma-CWG merger against the recent jump in Sigma Healthcare shares, forming a dim view of the stock's valuation.

2023 was a tough year for investors in ASX lithium stocks, but don't fret lithium bulls, this broker is suggesting some Christmas cheer!